($) USD (Default)
  • ($) AUD
  • (€) EUR
  • ($) CAD
  • ($) NZD
  • (£) GBP

FTPP (Adipotide) Pre Mixed Peptide 2mg

$45.44$129.90

An experimental weight loss therapy called adipotide also known as FTPP, destroys the fat cells by aiming for their blood supply. The ftpp adipotide peptide has been the subject of extensive study, with promising results:

  • In animal studies, it has been shown to promote weight loss and reduce fat deposits.
  • To prevent weight gain, it starves fat cells of blood supply.
  • Even when the drug is stopped, the weight loss continues.

499 in stock

First time customer gets 15% discount code = 1storder

FTPP (Adipotide) Pre Mixed Peptide America

An experimental weight loss therapy called adipotide also known as FTPP, destroys the fat cells by aiming for their blood supply.

The main purpose of FTPP Adipotide Pre Mixed Peptide resides in its effectiveness in stimulating rapid weight loss & obesity, through the targeting of body fat. Testing of FTPP Adipotide pre mixed peptide on mice and monkeys has yielded positive results in its efficiency with regards to the intended outcome to facilitate the treatment of rapid weight loss and improved insulin resistance.

Adipotide’s functional design profile is for the active targeting of specific blood vessels which are responsible for delivering blood to adipose tissue (body fat). Blood vessels shrink, as a result, a process which induces apoptosis among the fat cells – i.e. the body feeds on the fat cells as its most immediate source of oxygen which would have otherwise been more abundant in the blood as well as the resultant energy which would have been synthesized from other sources.

Adipotide (FTPP) peptides, America research suggests aids the process of weight loss via a fast-acting fat-reduction action process which can reduce your weight within a matter of a few months. The process particularly targets abdominal fat for mass reduction.


FTPP Adipotide Pre Mixed Peptide Benefits America

Tolerance to Glucose:
Fasting glucose levels are used to confirm a person’s glucose tolerance, a popular parameter for diagnosing diabetes. Another method involves the patient consuming a predetermined amount of glucose, which is then used to estimate the patient’s blood sugar levels.
Diet and exercise have traditionally been used to treat metabolic syndromes like diabetes, but the results can take months, not years, to show significant improvement. As a result, Metformin or insulin is commonly prescribed to people with type 2 diabetes.

America Research into FTPP Adipotide Pre Mixed Peptide has shown advancement in glucose tolerance that is independent of weight. When white fat is reduced, glucose tolerance can also be reduced, regardless of a patient’s weight, as demonstrated by this study’s findings. These findings shed light on the mechanisms that lead to diabetes in the first place, and they also point the way to new treatment options for the condition.

America FTPP Adipotide Pre Mixed peptide has been shown to alter fat cell density and enhance glucose tolerance even without weight loss, making it more likely that the peptide causes significant fat loss rather than an indirect effect.

Fat loss:
Clinical trials on adipotide’s fat-eliminating abilities were conducted in the United States. The ability of this new peptide to induce apoptosis in the vessels that supply blood to the white adipose tissues was demonstrated in rhesus monkey studies. Because there are no blood cells, these fat cells will die as a result. This resulted in an increase in insulin sensitivity as well as an increase in rapid weight loss. To some extent, these changes can be attributed to adipotide’s ability to alter the monkeys’ eating habits, as the monkeys who lost weight also lost their appetite.

Adipotide has been linked to a membrane protein receptor known as prohibitin (PHB), which is found in the blood vessels of white fat tissues and some cancer cells, according to recent America research. Distinctly in the blood vessels that supply blood to adipose and cancerous tissues, prohibitin (PHB) is found to be expressed and may be used for both therapeutic and diagnostic purposes in adipotide testing.

Cancer:
Due to the abundance of blood vessels, cancerous tissues are able to proliferate and become metastatic. Therefore, Prohibiin, a protein found in various cancers, could be used to narrow the focus of cancer treatment and reduce or eliminate the side effects associated with chemotherapy’s damage to healthy tissues.

There is also the option America to buy FTPP Adipotide Peptide vial and FTPP Nasal Spray.


References:

[1] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3666164/

[2] https://www.sciencedaily.com/ releases/2011/11/11110914 3009.htm

Molecular Weight: 2611.41 g/mol

Molecular Formula: C152 H525 N44 O42

Sequence: Cys Lys Gly Gly Arg Ala Lys Asp Cys Gly Gly (Lys-Leu-Ala-Lys-Leu-Ala-Lys)2

FTPP Adipotide HPLC Certificate


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our America Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

Pen instructions

All pre-mixed cartridges are mixed with 2ml bacteriostatic water, pens will release approximately 0.5ml per 60 dials on the pen (one full pen)

To achieve the number of micrograms (mcg) that 1 dial on the pen will release you will need to simply divide the amount of product:

2mg = 2000mcg

5mg = 5000mcg

by the full amount of pen dials (which will always be 240)

E.g., 5000mcg divided by 240 = 20.83, therefore 1 dial on the pen for all 5mg products will release approximately 20.83mcg.